BRIEF-Immunocellular Therapeutics Ltd - Anthony Gringeri Resigs From Board And As President And CEO Of Co
BRIEF-Immunocellular Therapeutics Ltd - Anthony Gringeri Resigs From Board And As President And CEO Of Co
簡介-免疫細胞治療有限公司-Anthony Gringeri辭去董事會職務，擔任公司總裁兼首席執行官
Oct 15 (Reuters) - ImmunoCellular Therapeutics Ltd :
* IMMUNOCELLULAR THERAPEUTICS LTD - ANTHONY GRINGERI NOTIFIED CO HE RESIGNED FROM BOARD AND AS PRESIDENT AND CEO OF CO, EFFECTIVE AS OF OCT 15, 2018
* IMMUNOCELLULAR THERAPEUTICS - DAVID FRACTOR NOTIFIED CO OF HIS RESIGNATION AS CFO - SEC FILING
Source text: () Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
路透10月15日電-免疫細胞治療有限公司(ImmunoCcell Treateutics Ltd)：*ImmunoCcell Treateutics Ltd-Anthony Gringeri通知CO他辭去了董事會職務，並辭去CO總裁兼首席執行官一職，自2018年10月15日起生效*免疫細胞治療公司-David FRACTOR通知CO他辭去CFO-SEC文件源文本：()進一步的公司報道：(Reurs.Briefs@thomsonreurs.com；)
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。